Antineutrophil cytoplasmic antibody-associated vasculitis and VEXAS syndrome: comment on the article by Muratore et al
- PMID: 36716119
- DOI: 10.1002/art.42466
Antineutrophil cytoplasmic antibody-associated vasculitis and VEXAS syndrome: comment on the article by Muratore et al
Comment in
-
Reply.Arthritis Rheumatol. 2023 Aug;75(8):1492-1493. doi: 10.1002/art.42467. Epub 2023 May 23. Arthritis Rheumatol. 2023. PMID: 36716123 No abstract available.
Comment on
-
VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With Vasculitis.Arthritis Rheumatol. 2022 Apr;74(4):665-670. doi: 10.1002/art.41992. Epub 2022 Mar 3. Arthritis Rheumatol. 2022. PMID: 34611997 Free PMC article.
References
REFERENCES
-
- Muratore F, Marvisi C, Castrignanò P, et al. VEXAS syndrome: a case series from a single-center cohort of Italian patients with vasculitis. Arthritis Rheumatol 2022;74:665-70.
-
- Ross C, Elfassy HL, Makhzoum JP. Somatic mutation in UBA1 and ANCA-associated vasculitis. J Rheumatol 2021;48:1626-7.
-
- Koster MJ, Kourelis T, Reichard KK, et al. Clinical heterogeneity of the VEXAS syndrome: a case series. Mayo Clin Proc 2021;96:2653-9.
-
- Poulter J, UKGCA/VEXAS Consortium, Morgan A, et al. A high-throughput amplicon screen for somatic UBA1 variants in cytopenic and giant cell arteritis cohorts. J Clin Immunol 2022;42:947-51.
-
- Afsahi V, Christensen RE, Alam M. VEXAS syndrome in dermatology. Arch Dermatol Res 2023;315:161-4.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources